InspireMD Statistics

Total Valuation

InspireMD has a market cap or net worth of $104.30 million. The enterprise value is $88.35 million.

Market Cap	104.30M
Enterprise Value	88.35M

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

InspireMD has 41.72 million shares outstanding. The number of shares has increased by 43.97% in one year.

Current Share Class	41.72M
Shares Outstanding	41.72M
Shares Change (YoY)	+43.97%
Shares Change (QoQ)	+2.02%
Owned by Insiders (%)	19.72%
Owned by Institutions (%)	23.80%
Float	28.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.57
Forward PS	15.06
PB Ratio	4.02
P/TBV Ratio	5.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.17.

Current Ratio	2.81
Quick Ratio	2.37
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -123.51% and return on invested capital (ROIC) is -73.70%.

Return on Equity (ROE)	-123.51%
Return on Assets (ROA)	-59.42%
Return on Invested Capital (ROIC)	-73.70%
Return on Capital Employed (ROCE)	-174.29%
Revenue Per Employee	$82,163
Profits Per Employee	-$481,174
Employee Count	86
Asset Turnover	0.16
Inventory Turnover	2.12

Taxes

In the past 12 months, InspireMD has paid $59,000 in taxes.

Income Tax	59,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.97% in the last 52 weeks. The beta is 0.60, so InspireMD's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-11.97%
50-Day Moving Average	2.43
200-Day Moving Average	2.64
Relative Strength Index (RSI)	51.39
Average Volume (20 Days)	109,636

Short Selling Information

The latest short interest is 314,576, so 0.75% of the outstanding shares have been sold short.

Short Interest	314,576
Short Previous Month	375,897
Short % of Shares Out	0.75%
Short % of Float	1.09%
Short Ratio (days to cover)	2.90

Income Statement

In the last 12 months, InspireMD had revenue of $7.07 million and -$41.38 million in losses. Loss per share was -$0.83.

Revenue	7.07M
Gross Profit	1.49M
Operating Income	-42.31M
Pretax Income	-25.46M
Net Income	-41.38M
EBITDA	-41.96M
EBIT	-42.31M
Loss Per Share	-$0.83

Full Income Statement

Balance Sheet

The company has $19.37 million in cash and $3.42 million in debt, giving a net cash position of $15.95 million or $0.38 per share.

Cash & Cash Equivalents	19.37M
Total Debt	3.42M
Net Cash	15.95M
Net Cash Per Share	$0.38
Equity (Book Value)	20.24M
Book Value Per Share	0.62
Working Capital	16.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.58 million and capital expenditures -$1.67 million, giving a free cash flow of -$31.24 million.

Operating Cash Flow	-29.58M
Capital Expenditures	-1.67M
Free Cash Flow	-31.24M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross Margin	21.06%
Operating Margin	-598.75%
Pretax Margin	-584.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InspireMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.97%
Shareholder Yield	-43.97%
Earnings Yield	-39.67%
FCF Yield	-29.95%

Analyst Forecast

The average price target for InspireMD is $4.50, which is 80.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	80.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.

Last Split Date	Apr 27, 2021
Split Type	Reverse
Split Ratio	1:15

Scores

InspireMD has an Altman Z-Score of -11.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.72
Piotroski F-Score	2